ACUTE KIDNEY INJURY IS INDEPENDENTLY ASSOCIATED WITH ALL-CAUSE MORTALITY FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION

THE AIM. To determine clinical value of acute kidney injury (AKI) in the setting of allogeneic hematopoietic stem cell transplantation (HSCT) for mortality along postransplant period.

PATIENTS AND METHODS. Ninety hematopoietic stem cell transplantat (HSCT) recipients (46 males, 44 females) were enrolled in the observational prospective study. Clinical and laboratory data were monitored and assessed 7 days prior to HSCT (week 0), on the posttransplant weeks 1, 2, 3, 4 and 5. AKI was diagnosed according to KDIGO (Kidney Disease Improving Global Outcomes) guidelines. All-cause mortality was registered along 1 year of posttransplant period. AKI associations with death risk were estimated in cumulative survival analysis and Cox multivariate regression models adjusted for other confounders.

RESULTS. AKI was diagnosed in 67 (74%) out of 90 patients. The majority of patients (84%) suffered from AKI 1 stage (KDIGO). AKI 2+3 stage (KDIGO) was found in 16% of patients. Renal replacement therapy was used in 4 (6%) patients with AKI. Cumulative survival rate following HSCT reached 75%. 28 deaths (31%) were registered within 1 year following HSCT. AKI was associated with lower cumulative survival following HSCT. AKI was independently associated with the risk of death according to multivariate Cox regression analyses adjusted for other confounders.

CONCLUSION. AKI may be considered as a significant clinical predictor of unfavorable allogeneic HSCT outcome, taking into account its independent association with increased risk of posttransplant all-cause mortality.

1. Zeng X, McMahon GM, Brunelli SM et al. Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals. Clin J Am Soc Nephrol 2014;9(1):12–20. DOI: 10.2215/CJN.02730313

2. Hsu RK, Hsu C. The Role of Acute kidney Injury in Chronic Kidney Disease. Semin Nephrol 2016;36(4):283–292. DOI: 10.1016/j.semnephrol.2016.05.005

3. Chertow GM, Burdick E. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005;16(11):3365–3370. DOI: 10.1681/ASN.2004090740

4. Sawhney S, Marks A, Fluck N et al. Intermediate and Long-term Outcomes of Survivals of Acute Kidney Injury Episodes: A Large Population-Based Cohort Study. Am J Kidney Dis 2017;69(1):18–28. DOI: 10.1053/j.ajkd.2016.05.018

5. Smirnov KA, Dobronravov VA, Afanasiev BV et al. Dynamics of kidney injury biomarkers following hematopoietic stem cell transplantation (pilot study). Nephrology (Saint-Petersburg) 2015;19(6):28–33 (In Russ.)

6. Dobronravov VA, Smirnov KA, Afansiev BV et al. Acute kidney injury and tubular biomarkers after hematopoietic stem cell transplantation. Ter Arkh 2016;2016;88(6):14–20

7. Krishnappa V, Gupta M, Manu G et al. Acute Kidney Injury in Hematopoietic Stem Cell Transplantation: A Review. Int J Nephrol 2016: 5163789. DOI: 10.1155/2016/5163789

8. Ando M. An Overview of Kidney Disease Following Hematopoietic Stem Cell Transplantation. Intern Med 2018;57(11):1503–1508. DOI: 10.2169/internalmedicine.9838-17

9. Dobronravov VA. The review of acute kidney injury pathophysiology. In: Smirnov AV, Dobronravov VA, Rumjancev A Sh, Kayukov IG. Acute kidney injury. MIA, M., 2015; 30–79

10. Parovichnikova EN, Mavrina ES, Surin VL i soavt. Metodi monitoringa minimalnoj rezidualnoj bolezni u bolnih ostrim limfoblastnim leikozom. Gematol. i transfuziol. 2013;58(3):46–48

11. Hahn T, Rondeau C, Shaukat A et al. Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patients. Bone Marrow Transplant 2003; 32(4):405–410. DOI: 10.1038/sj.bmt.1704144

12. Sawinski D. The Kidney Effects of Hematopoietic stem Cell Transplantation. Advances in Chronic Kidney Disease 2014;21(1):96–105. DOI: 10.1053/j.ackd.2013.08.007

13. Lopes JA, Jorge S. Acute kidney injury following HCT: incidence, risk factors and outcome. Bone Marrow transplantation 2011;46(11):1399–1408. DOI: 10.1038/bmt.2011.46

14. Kizilbash SJ, Kashtan CE, Chavers BM. Acute kidney injury and the risk of mortality in children undergoing hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2016;22(7):1264–1270. DOI: 10.1016/j.bbmt.2016.03.014

15. Shingai N, Morito T, Najima Y et al. Early-onset acute kidney injury is a poor prognostic sign for allogeneic SCT recipients. Bone Marrow Transplantation 2015;50:1557–1562. DOI: 10.1038/bmt.2015.188

16. Keller SP, Kovacevic A, Howard J. Evidence of cardiac injury and arrhythmias in dogs with acute kidney injury. J Small Anim Pract 2016;57(8):402–408. DOI: 10.1111/jsap.12495

17. Wen X, Murugan R, Peng Z. Pathophysiology of acute kidney injury: a new perspective. Contrib Nephrol 2010;165:39–45. DOI: 10.1159/000313743

18. Grams ME, Rabb H. The distant organ effects of acute kidney injury. Kidney Int 2012;81(10):942–948. DOI: 10.1038/ki.2011.241

19. Yap SC, Lee HT. Acute kidney injury and extrarenal organ dysfunction: new concepts and experimental evidence. Anesthesiology 2012; 116:1139–1148. DOI: 10.1097/ALN.0b013e31824f951b

20. Fein JA, Shimoni A, Labopin M et.al. The impact of individual comorbidities on non-relapse mortality following allogeneic hematopoietic stem cell transplantation. Leukemia. 2018;32(8):1787–1794. DOI: 10.1038/s41375-018-0185-y